MATERNUS-Kliniken AG Statistics
Want to see DE:MAK full AI Analyst Report?
MATERNUS-Kliniken AG (MAK) Stock Statistics & Valuation Metrics
Total Valuation
MATERNUS-Kliniken AG has a market cap or net worth of EUR 17.09M. The enterprise value is EUR 221.67M.
- Market Cap
- EUR 17.09M
- Enterprise Value
- EUR 221.67M
Share Statistics
MATERNUS-Kliniken AG has 20,970,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 20,970,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
MATERNUS-Kliniken AG’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -4.75%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -4.75%
- Return on Capital Employed (ROCE)
- -0.11
- Revenue Per Employee
- 83.93K
- Profits Per Employee
- -9,886.202
- Employee Count
- 1,406
- Asset Turnover
- 0.79
- Inventory Turnover
- 232.84
Valuation Ratios
The current PE Ratio of MATERNUS-Kliniken AG is -1.25. MATERNUS-Kliniken AG’s PEG ratio is -0.15.
- PE Ratio
- -1.25
- PS Ratio
- 0.14
- PB Ratio
- -0.21
- Price to FCF
- 1.34
- Price to Operating Cash Flow
- 1.06
- PEG Ratio
- -0.15
Income Statement
In the last 12 months, MATERNUS-Kliniken AG had revenue of 118.00M and earned -13.90M in profits. Earnings per share was -0.66.
- Revenue
- 118.00M
- Gross Profit
- 23.00M
- Operating Income
- -6.12M
- Pretax Income
- -12.76M
- Net Income
- -13.90M
- EBITDA
- 4.07M
- Earnings Per Share (EPS)
- -0.66
Cash Flow
In the last 12 months, operating cash flow was 16.11M and capital expenditures -3.32M, giving a free cash flow of 12.79M billion.
- Operating Cash Flow
- 16.11M
- Free Cash Flow
- 12.79M
- Free Cash Flow per Share
- 0.61
Dividends & Yields
MATERNUS-Kliniken AG pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 74.81%
- Earnings Yield
- -80.14%
Stock Price Statistics
- Beta
- 0.39
- 52-Week Price Change
- -26.58%
- 50-Day Moving Average
- 0.89
- 200-Day Moving Average
- 0.98
- Relative Strength Index (RSI)
- 42.96
- Average Volume (3m)
- 3,007
Important Dates
MATERNUS-Kliniken AG upcoming earnings date is Apr 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 20, 2026
- Next Earnings Date
- Apr 23, 2027
- Ex-Dividend Date
- ―
Financial Position
MATERNUS-Kliniken AG as a current ratio of 0.21, with Debt / Equity ratio of -227.32%
- Current Ratio
- 0.21
- Quick Ratio
- 0.20
- Debt to Market Cap
- 5.74
- Net Debt to EBITDA
- 44.02
- Interest Coverage Ratio
- -0.76
Taxes
In the past 12 months, MATERNUS-Kliniken AG has paid 1.09M in taxes.
- Income Tax
- 1.09M
- Effective Tax Rate
- -0.09
Enterprise Valuation
MATERNUS-Kliniken AG EV to EBITDA ratio is 152.70, with an EV/FCF ratio of 17.01.
- EV to Sales
- 1.82
- EV to EBITDA
- 152.70
- EV to Free Cash Flow
- 17.01
- EV to Operating Cash Flow
- 13.50
Balance Sheet
MATERNUS-Kliniken AG has EUR 5.05M in cash and marketable securities with EUR 205.41M in debt, giving a net cash position of -EUR 200.36M billion.
- Cash & Marketable Securities
- EUR 5.05M
- Total Debt
- EUR 205.41M
- Net Cash
- -EUR 200.36M
- Net Cash Per Share
- -EUR 9.55
- Tangible Book Value Per Share
- -EUR 4.49
Margins
Gross margin is 14.25%, with operating margin of -6.19%, and net profit margin of -11.48%.
- Gross Margin
- 14.25%
- Operating Margin
- -6.19%
- Pretax Margin
- -11.01%
- Net Profit Margin
- -11.48%
- EBITDA Margin
- 1.19%
- EBIT Margin
- -6.19%
Analyst Forecast
The average price target for MATERNUS-Kliniken AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.73%
- EPS Growth Forecast
- -1.80%
Scores
- Smart Score
- 4
- AI Score
- 47

